With a focus on actionable insights and strategic value, The Business Research Company’s 2026 market reports include market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.
How Much Will The Disease Management Apps Market Be Worth By 2030?
The disease management apps market has experienced substantial growth in recent years. It will grow from $13.05 billion in 2025 to $14.75 billion in 2026 at a compound annual growth rate (CAGR) of 13.0%. The growth observed in the historic period is primarily due to the rising prevalence of chronic diseases, increasing smartphone penetration, growing adoption of digital health solutions, demand for continuous patient monitoring, and the expansion of telehealth services.
The disease management apps market is projected for significant expansion over the coming years, anticipated to achieve a size of $24.18 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.2%. This projected growth is driven by several factors, including developments in AI-powered health analytics, the incorporation of wearable health technology, an increasing emphasis on preventive health measures, wider adoption of remote care solutions, and initiatives aimed at optimizing healthcare costs. Key trends anticipated during this period encompass the integration of remote patient monitoring, the development of personalized disease care pathways, improved medication adherence strategies, real-time analysis of health data, and chronic care management facilitated by wearables.
Get Access To A Free Disease Management Apps Market Report Sample:
The Key Driver Behind The Disease Management Apps Market’s 13.2% CAGR
The rising occurrence of chronic ailments is anticipated to fuel the expansion of the disease management apps market in the future. Chronic conditions are defined as persistent medical issues that last for an extended duration, typically three months or more. Disease management applications assist individuals with chronic diseases by offering functionalities to monitor symptoms, record medication intake, keep track of vital signs, and identify specific triggers. As an illustration, in June 2024, data from the National Health Service, a UK-based government body, revealed that 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes in 2023. This figure represents an 18% surge from the 3,065,825 cases reported in 2022. Consequently, the growing incidence of chronic conditions is propelling the growth of the disease management apps market moving forward.
Disease Management Apps Market Classification: Main Segments And Detailed Subsegments
The disease management apps market covered in this report is segmented –
1) By Platform Type: iOS, Android, Other Platform Types
2) By Device: Smartphones, Tablets, Wearables
3) By Indication: Obesity, Cardiovascular Issues, Mental Health, Diabetes, Other Indications
Subsegments:
1) By iOS: IPhone Apps, iPad Apps
2) By Android: Smartphone Apps, Tablet Apps
3) By Other Platform Types: Windows Mobile Apps, Web-Based Apps
Disease Management Apps Market Strategic Shifts: What Leading Players Are Prioritizing
Leading companies within the disease management apps market are concentrating on technological breakthroughs, particularly GenAI, to enhance their market profitability. GenAI, an artificial intelligence solution, facilitates the automated generation of clinical summary reports and fosters improved communication channels between patients and healthcare providers. As an illustration, Huma Therapeutics, a UK-based healthcare technology firm, introduced its GenAI artificial intelligence (AI) disease management platform technology, powered by Google Cloud, in August 2023. This innovative technology is specifically engineered for integration into their existing disease-management platform, aiming to refine decision-making tools for diagnostic treatments and subsequent recommendations.
Disease Management Apps Market Company Analysis: Major Industry Participants
Major companies operating in the disease management apps market are Alphabet Inc.; International Business Machines Corporation; Siemens Healthineers AG; Koninklijke Philips N.V.; Garmin International Inc.; DexCom Inc.; Epic Systems Corporation; Teladoc Inc.; Fitbit LLC; athenahealth Inc.; Allscripts Healthcare Solutions Inc.; Omada Health Inc.; Calm.com Inc.; Livongo Health Inc.; American Well Corporation; MyFitnessPal Inc.; Talkspace Inc.; Noom Inc.; Ada Health GmbH; Healthy.io Ltd.; Medisafe International LLC; Sleep Cycle AB; Buoy Health Inc.; Azumio Inc.; Propeller Health Inc.; Welldoc Inc.; Informed Data Systems Inc.; Curable Inc.
Get Full Access To The Disease Management Apps Market Report 2026:
Disease Management Apps Market Global Regional Breakdown: Key Regions Analyzed
North America was the largest region in the disease management apps market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the disease management apps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
